These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7974358)

  • 1. The significant enhancement of fibrinolysis by calcium ion in a cell free system: the shortening of euglobulin clot lysis time by calcium ion.
    Kojima Y; Urano T; Kojima K; Serizawa K; Takada Y; Takada A
    Thromb Haemost; 1994 Jul; 72(1):113-8. PubMed ID: 7974358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of plasminogen activator inhibitor type 1 by activated factor XII plays a role in the enhancement of fibrinolysis by contact factors in-vitro.
    Tanaka A; Suzuki Y; Sugihara K; Kanayama N; Urano T
    Life Sci; 2009 Jul; 85(5-6):220-5. PubMed ID: 19500599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated protein C attenuates coagulation-associated over-expression of fibrinolytic activity by suppressing the thrombin-dependent inactivation of PAI-1.
    Urano T; Castellino FJ; Ihara H; Suzuki Y; Ohta M; Suzuki K; Mogami H
    J Thromb Haemost; 2003 Dec; 1(12):2615-20. PubMed ID: 14675098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bidirectional functions of thrombin on fibrinolysis: Evidence of thrombin-dependent enhancement of fibrinolysis provided by spontaneous plasma clot lysis.
    Tomczyk M; Suzuki Y; Sano H; Brzoska T; Tanaka H; Urano T
    Thromb Res; 2016 Jul; 143():28-33. PubMed ID: 27179129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma fibrinogen level is an important determinant of prolonged euglobulin clot lysis time in hemodialysis patients.
    Borawski J; Myśliwiec M
    Clin Appl Thromb Hemost; 2001 Oct; 7(4):296-9. PubMed ID: 11697712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Euglobulin clot lysis time reveals a high frequency of fibrinolytic activation in trauma.
    Ilich A; Kumar V; Ferrara MJ; Henderson MW; Noubouossie DF; Jenkins DH; Kozar RA; Park MS; Key NS
    Thromb Res; 2021 Aug; 204():22-28. PubMed ID: 34111811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.
    Guimarães AH; Rijken DC
    Thromb Haemost; 2004 Mar; 91(3):473-9. PubMed ID: 14983222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corn trypsin inhibitor decreases tissue-type plasminogen activator-mediated fibrinolysis of human plasma.
    Nielsen VG
    Blood Coagul Fibrinolysis; 2009 Apr; 20(3):191-6. PubMed ID: 19657316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human thrombin and calcium bound factor Xa significantly shorten tPA-induced fibrin clot lysis time via neutralization of plasminogen activator inhibitor type 1 activity.
    Urano T; Nagai N; Matsuura M; Ihara H; Takada Y; Takada A
    Thromb Haemost; 1998 Jul; 80(1):161-6. PubMed ID: 9684803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of endothelin-1 on some hemostatic parameters in normotensive rats.
    Pietraszek M; Chabielska E; Azzadin A; Pawlak R; Buczko W
    Acta Physiol Hung; 1996; 84(3):329-30. PubMed ID: 9219627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E1 (PGE1): effect on the human fibrinolytic system.
    Narain VS; Saran RK; Dwivedi SK; Puri VK; Hasan M
    Indian Heart J; 1989; 41(5):326-9. PubMed ID: 2599544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contact activation prolongs clot lysis time in human plasma: role of thrombin-activatable fibrinolysis inhibitor and Factor XIII.
    Nielsen VG; Steenwyk BL; Gurley WQ
    J Heart Lung Transplant; 2006 Oct; 25(10):1247-52. PubMed ID: 17045938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma TAFI levels influence the clot lysis time in healthy individuals in the presence of an intact intrinsic pathway of coagulation.
    Mosnier LO; von dem Borne PA; Meijers JC; Bouma BN
    Thromb Haemost; 1998 Nov; 80(5):829-35. PubMed ID: 9843179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
    Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
    Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The defective down regulation of fibrinolysis in haemophilia A can be restored by increasing the TAFI plasma concentration.
    Mosnier LO; Lisman T; van den Berg HM; Nieuwenhuis HK; Meijers JC; Bouma BN
    Thromb Haemost; 2001 Oct; 86(4):1035-9. PubMed ID: 11686321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor.
    von dem Borne PA; Cox LM; Bouma BN
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):251-7. PubMed ID: 16651866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma fibrinolytic activators and their inhibitors in women suffering from early recurrent abortion of unknown etiology.
    Gris JC; Neveu S; Mares P; Biron C; Hedon B; Schved JF
    J Lab Clin Med; 1993 Nov; 122(5):606-15. PubMed ID: 8228580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly stable plasminogen activator inhibitor type one (VLHL PAI-1) protects fibrin clots from tissue plasminogen activator-mediated fibrinolysis.
    Jankun J; Aleem AM; Selman SH; Skrzypczak-Jankun E; Lysiak-Szydlowska W; Grafos N; Fryer HJ; Greenfield RS
    Int J Mol Med; 2007 Nov; 20(5):683-7. PubMed ID: 17912461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new euglobulin clot lysis assay for global fibrinolysis.
    Smith AA; Jacobson LJ; Miller BI; Hathaway WE; Manco-Johnson MJ
    Thromb Res; 2003; 112(5-6):329-37. PubMed ID: 15041279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protamine enhances fibrinolysis by decreasing clot strength: role of tissue factor-initiated thrombin generation.
    Nielsen VG
    Ann Thorac Surg; 2006 May; 81(5):1720-7. PubMed ID: 16631662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.